Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-25

Clinical Trial Update: Exosomes in Patients With Ocular Involvement of Sjögren's Syndrome [EARLY_Phase 1]

View source ↗

Summary

This is a Phase 1 study evaluating an exosome-based therapy for ocular involvement in Sjögren's syndrome, sponsored by Guangdong ProCapZoom Biosciences Co., Ltd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exosome therapy (ocular involvement in Sjögren's syndrome) (exosome-based therapy)

Snippet

Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd. | Conditions: Sjögren's Syndrome | EARLY_Phase 1 | Status: NOT_YET_RECRUITING